ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

2022 American Transplant Congress

June 4-8, 2022 in Boston, MA

The ATC program is built in the Eastern Time Zone.

View by Title View Sessions View Topics
View by Date
Jump to:  View All • a b c [d] e f g h i j k l m n o p q r s t u v w x y z
  • Daratumumab for Recurrence of Proliferative Glomerulonephritis with Monoclonal Immunoglobulin Deposits in a Post-Kidney Transplant Recipient: A Case Report

    K. Progar1, T. Alhamad2, H. Murad3, A. Java4, A. Malone5, J. Gaut6, R. Delos Santos7, M. Merzkani8

  • Daratumumab Therapy Achieves Dialysis Independence in Kidney Transplant Recipients with Resistant Proliferative Glomerulonephritis with Monoclonal Immunoglobulin Deposits

    P. Yenebere, R. Daloul

  • Data-Driven Clustering Distinguishes Infection from Rejection During Hospital Admissions Following Pediatric Lung Transplantation

    C. D. Britto1, D. Boyer2, G. Visner3, G. Priebe4, L. Midyat3

  • DCD and AKI Kidneys Experiencing DGF as a Platform for the Study of Adaptive Repair

    B. Bussolati1, S. Da Sacco2, A. Asthana3, L. N. Byers3, L. Perin4, M. S. Garner3, B. Sharda3, A. C. Farney3, C. J. Jay3, R. J. Stratta3, S. J. Walker5, G. Orlando3

  • DCD Liver Grafts Can Safely be Used for Recipients with Grade 1-2 Portal Vein Thrombosis

    L. A. Mercado1, H. K. Bhangu1, K. R. Musto2, K. D. Watt3, B. Taner4, C. B. Rosen5, T. Taner5, L. Yang1, D. M. Harnois1, J. D. LeGout6, K. P. Croome4

  • DCD vs DBD Pancreas Transplant Outcome – A Comprehensive Registry Analysis

    A. C. Gruessner1, S. J. Saggi2, R. Gruessner1

  • Dd-cfdna Correlates With Acute Rejection In The Setting Of Bk Viremia After Kidney Transplantation

    N. M. Ali1, J. Miles2, V. Tatapudi1, R. Chand1, R. Montgomery1

  • dd-cfDNA Varies Among Diagnostics Groups of Pulmonary AMR

    D. Levine1, C. Giner1, C. Pham2, R. Woodward3, A. Roux4

  • De Novo Anti-Brush Border Antibody Disease in a Kidney Transplant Recipient

    P. Yenebere, D. Ibrahim, T. Nadasdy, R. Daloul

  • De Novo Donor-Specific Antibody Development in Heart Transplant Recipients Following COVID-19 Vaccination

    M. Cheng1, O. Behbahani-Nejad1, D. Gupta2

  • De Novo Donor-Specific Antibody Development with Mycophenolate versus Azathioprine in Lung Transplant Recipients

    A. Prom1, K. Walter2, K. Gomez3, C. Doligalski1, L. Lobo1, R. Evans1

  • De Novo DSA in the Setting of Stable Allograft Function is a Benign Finding

    R. J. Knight, E. A. Graviss, D. T. Nguyen, T. N. Eagar, S. G. Yi, H. Podder, M. Hobeika, R. McMillan, A. O. Gaber

  • De Novo Fibrinogen Alpha Chain Amyloidosis in Kidney Allograft

    T. Khaja1, L. Truong2, G. Nassar1

  • De Novo Focal Segmental Glomerulosclerosis in the Kidney Allograft: Association with Alloimmunity Leading to Poor Outcome

    J. Leon1, J. Duong Van Huyen2, A. Abderrahmane1, D. Anglicheau1, C. Legendre1, M. Rabant2

  • De Novo Lipoprotein-X Causing Hypercholesterolemia and Acute Kidney Injury (AKI) in Simultaneous Liver Kidney Transplant (SLKT) Patient

    H. Me, S. S. Nair, M. Al-Qaisi, M. Ryan, L. Kodali, B. Aqel

  • De-Novo Belatacept Therapy is Associated with an Increased Risk of Invasive CMV Disease After Kidney Transplantation

    G. Petrossian1, J. Ortiz2, K. Addonizio1, A. Hsiao1, L. Teixeira1, N. Koizumi3, R. James3, S. Patel4, D. Conti2, R. Plews2

  • De-Novo Belatacept Therapy is Associated with Higher Levels of BK Viremia and Lower Rates of BK Clearance in Kidney Transplantation Patients

    G. Petrossian1, J. Ortiz2, K. Addonizio1, L. Teixeira1, A. Hsiao1, R. James3, N. Koizumi3, S. Patel4, D. Conti2, R. Plews2

  • Deceased Donor Kidney Transplantation from Donors with Acute Kidney Injury: Realities and Costs

    S. Iskhagi1, R. Shahbazov1, A. Ball1, S. Loerzel1, E. Shaban2, B. Gallay2, R. Hod Dvorai3, J. Leggat2, M. Hanlon1, R. Saidi1

  • Deceased Donor Organ Flush with Similar Volumes of HTK and UW at a Single U.S. Organ Procurement Organization: Adult and Pediatric Data

    A. E. Mangus1, C. Kubal2, B. Ekser3, P. Mihaylov4, A. J. Lutz1, J. Fridell5, R. Mangus6

  • Deceased Donor Procurement Biopsy Practices, Interpretation, and Histology-Based Decision Making: A Survey of US Transplant Centers

    V. Fleetwood1, D. Axelrod2, Y. Caliskan1, H. Randall1, J. Wellen3, M. Lichtenberger3, C. Dedert1, R. Rothweiler4, G. F. Marklin4, D. Brockmeier4, M. A. Schnitzler1, S. A. Husain5, S. Mohan5, B. Kasiske6, M. Cooper7, K. L. Lentine1

  • Deceased Donor Vein Extension Grafts for Right Living-Donor Kidney Transplantation

    A. Meinders, S. G. Yi, M. Hobeika, R. McMillan, H. Podder, A. Gaber, R. J. Knight

  • Decellularized Human Pancreatic Extracellular Matrix-Based Physiomimetic Microenvironment for Human Islet Culture

    A. Asthana1, D. Chaimov1, R. Tamburrini2, S. J. Walker3, G. Orlando1

  • Decision-Making Among HCV-Negative Transplant Candidates Offered Organs from Donors with HCV Infection

    E. Schnellinger1, E. Saine1, M. Liu1, J. Diamond1, M. Crespo1, S. Prenner1, V. Potluri1, C. Bermudez1, H. Mentch1, M. Moore2, B. Besharatian1, D. Goldberg3, F. Barg1, P. Reese1

  • Decreased Mortality from Sars-CoV-2 Infection in Kidney Transplant Recipients Over the Course of the Pandemic

    Y. Al Azzi, P. Loarte, C. Pynadath, L. Liriano, M. Ajaimy, S. Kapoor, H. Yaffe, M. Le, J. Graham, J. Rocca, S. Greenstein, M. Kinkhabwala, E. Akalin

  • Deep Learning Identifies Arterial Intimal Fibrosis in Kidney Transplant Biopsies

    K. Liu1, Z. Yi2, S. Ward3, F. Salem3, W. Zhang2

  • Deep Phenotyping Methods Highlight Recipient-Derived CD16+ NK and CD16+ Monocyte Infiltration During Kidney Transplant Rejection

    B. Lamarthée1, J. Callemeyn1, P. Koshy2, T. Debyser3, E. Van Loon1, A. Franken4, T. Van Brussel4, I. Arijs4, D. Lambrechts4, A. Senev1, T. Vaulet5, C. Tinel1, M. Naesens1

  • Deep-Learning Based Pathological Assessment of Frozen Procurement Kidney Biopsies

    Z. Yi1, C. Xi1, M. Menon2, P. Cravedi1, B. Murphy1, S. Ward1, F. Salem1, W. Zhang1

  • Defatting of Steatotic Liver Grafts by Normothermic Ex Vivo Liver Machine Perfusion with 2,4 Dinitrophenol

    J. M. Gassner1, J. Michelotto1, S. Moosburner1, F. Strobl1, A. L. Birkenfeld2, A. Kurzbach2, G. Shulman3, X. Zhang3, M. Selzner4, Y. Noguchi4, J. Pratschke1, I. M. Sauer1, N. Raschzok1

  • Defects in Kim-1 Do Not Result In Delayed Graft Function After Kidney Transplantation

    R. S. Suri1, J. Lee2, M. Ban3, B. Shrum2, O. Z. Ismail4, S. Leckie5, A. McIntyre3, Q. Xu6, S. H. Lee2, S. de Chickera2, R. A. Hegele2, L. Gunaratnam2

  • Deficiency of Antibody-Suppressor CXCR5+CD8+ T Cells (Not CD4+ Tregs) Drive High Alloantibody Production in CCR5 KO Kidney Transplant Recipients

    J. L. Han1, J. M. Zimmerer1, Q. Zeng2, S. Chaudhari1, C. K. Breuer2, G. L. Bumgardner1

  • Defining New Arterial and Arteriolar Lesions Accompanying Transplant Glomerulopathy: Potential Additions to the Histologic Assessment of ABMR

    A. Perkowska-Ptasinska1, D. Deborska-Materkowska2, M. Ciszek3, M. Myslak4, J. Chang5, J. Reeve6, P. Halloran7

  • Defining the Characteristics and Graft Outcomes of Kidney Transplant Recipients with Pre-Transplant Elevated Plasma Oxalate Levels

    D. Khan, N. Zhang, M. Keddis

  • Defining the Longitudinal Dynamics of Immune Cells in Blood in the First Year After Pediatric Liver Transplantation (pLTx)

    E. Chichelnitskiy1, L. Ruhl2, I. Goldschmidt3, A. Karch4, L. Antiga5, D. Debray6, L. Hierro7, D. Kelly8, V. McLin9, E. Nicastro10, J. Pawlowska11, P. Czubkowski11, R. Mikolajczyk12, U. Baumann13, C. Falk14

  • Degree of Pre-Liver Transplant Immune Dysfunction Correlates with Post-Transplant Cancer Recurrence

    G. S. Prakash1, G. G. Panayotova1, S. Simonishvili1, Y. Qin1, L. Jin1, T. Ayorinde1, L. J. Minze2, F. Paterno1, L. Brown1, A. Amin1, D. Liu1, R. Ghobrial2, J. V. Guarrera1, K. E. Lunsford1

  • Delayed Graft Function in Kidney Transplant Recipients is Associated with an Increased Risk f Post-Transplant Infections

    V. Manchala, B. Muth, E. Yousif, J. Turk, J. Blazel, M. Bloom, N. Garg, F. Aziz, M. Mohamed, A. Djamali, D. Mandelbrot, B. Astor, S. Parajuli

  • Delayed Graft Function in Living Donor Kidney Transplantation: Risk Factors and Outcomes

    G. Defelice1, A. Paramesh2, H. Jeon2, K. Atiemo2, M. Killackey2, A. Vijay2

  • Deletion of AIF-1 Promotes Kidney Reparative Macrophages and Prevents Fibrosis

    I. Husain, A. Dangi, X. Luo

  • Deletion of Fibroblastic Reticular Cell Derived Laminin A4 Impairs Lymph Node Vasculature and Conduits

    L. Li1, M. Shirkey1, W. Piao1, A. Kensiski1, V. Saxena1, T. Zhang1, X. Li2, J. Zhao2, S. Gavzy1, R. Abdi2, J. Bromberg1

  • Delivery of Extracellular Matrix Targeted Regulatory T Cells by Novel Nanofiber Coatings for Transplantation Therapies

    L. Gallon1, J. K. Carrow2, J. He1, Y. Sambandam1, X. Lai1, J. Mathew1, L. C. Palmer2, J. R. Leventhal1, Z. Zhang1, S. I. Stupp2

  • Delivery of Plasmin During Machine Perfusion or Cold Storage Flush Improves Early Transplant Outcomes in aRat Dcd Liver Transplant Model

    N. Abraham1, M. Zhang1, P. Cray2, R. Neill1, G. Cywinska1, J. Migaly1, R. Kahan1, A. Pontula1, J. Penaflor1, Q. Gao1, K. P. Samy1, J. J. Pollara2, V. Novokhatny3, M. G. Hartwig1, A. S. Barbas1

  • Delta Changes in Donor-Derived Cell-Free DNA (dd-cfDNA) Complement the Donor Fraction in Kidney Transplant Surveillance

    A. Wiseman1, M. Jagadeesan2, G. Gupta3, V. Rao4, M. Narayanan5, N. Agrawal6, G. Shekhtman6, Y. Fu6, K. Pinney6, S. Anand7

  • Demographic Characteristics of VCA Candidates and Recipients in the U.S.

    J. Wainright1, L. Cartwright1, A. Henderson1, W. Cherikh1, S. Booker1, D. Klassen2

  • Dendritic Cell Senescence as a Key Contributor to Transplant Rejection

    J. Zhao1, X. Li1, S. Jung1, H. Zhang1, V. Kasinath1, J. Azzi1, P. Sage1, J. Bromberg2, R. Abdi1

  • Depletion of Donor Macrophages Permits Post-Transplant Tolerance Induction

    M. Dilts1, A. Dangi2, X. Luo3

  • DEPTOR: A Novel Endothelial-Specific Regulator of Cell-Intrinsic Anti-Inflammation Following Transplantation

    C. Testini1, S. Bose1, K. Liu1, S. Kong1, E. Flynn1, M. Miovski1, J. Leyva-Rangel1, M. Laplante2, J. Wedel1, D. M. Briscoe1

  • Derivation of a Cardiac Risk Index for Use in Liver Transplantation for Non-Alcoholic Steatohepatitis

    P. Levy, C. Harrington, E. Cabrera, J. Gao, D. Gregory, C. Padilla, G. Crespo, L. VanWagner

  • Desensitization Protocol Consisting of High-Dose Intravenous Immunoglobulin, Plasmapheresis, and Rituximab in Highly Sensitized Kidney Transplant Recipients

    M. Okada, T. Hiramitsu, T. Tomosugi, K. Futamura, S. Narumi, N. Goto, Y. Watarai

  • Desensitization Protocol to Prevent Severe Oliguric Antibody-Mediated Rejection

    H. Ishida1, K. Unagami1, T. Kamzawa1, K. Omoto1, H. Shimizu1, K. Tanabe2

  • Desensitization Using Costimulatory Blockade and Bortezomib to Prevent DSA Formation and Rejection in Reconstructive Transplantation

    B. Oh, F. Messner, Y. Guo, G. Brandacher

  • Designing Continuous Distribution for Liver Allocation

    M. Mankowski1, N. Wood2, D. Segev3, S. Gentry2

  • Detection of Alloreactive CD8+ T Cell Responses and the Immunopeptidome That Elicits Their Activation

    A. B. Morris, X. Zhang, E. V. Peek, A. Hadley, C. Larsen

  • Detection of CMV Mediated Sub-Clinical Rejection by Urine Biomarkers

    S. Ghosh1, R. Sarwal1, C. Mark1, E. Reed2, J. Shoji3, S. Bunnapradist2, T. Sigdel3, M. Sarwal3

  • Detection of Early Graft Injury After Liver Transplantation with Blood-Bile Ratio of Tacrolimus: The TUBE Trial

    M. M. Pascale1, G. Bianco1, L. Ferri1, F. Giovinazzo1, A. Liguori2, G. Marrone2, A. Grieco2, S. Agnes1

  • Detection of Microbiota from Catheter Tip in Hemodialysis Patients During the Perioperative Period of Kidney Transplantation Based on Metagenomics: A Prospective Study

    Z. Yan, Y. Wang, W. Zeng, R. Xia, W. Deng, J. Xu, Y. Miao

  • Developing A Tool To Assess Psychosocial Determinants Of Health And Quality Of Life In Pediatric Liver Transplant Patients

    C. R. Christmann1, S. Rath2, S. Sakhuja3, N. Galvan2

  • Development and Validation of a Kidney Transplant-Specific Measure of Treatment Burden

    E. Lorenz1, T. Petterson1, I. Zaniletti1, K. Lackore1, B. Johnson1, M. Mai2, S. Nair3, A. Bentall1, K. Yost1, D. Eton1

  • Development and Validation of a Machine Learning Based Virtual Biopsy System in Kidney Transplant Patients

    D. Yoo1, G. Divard1, M. Raynaud1, A. Bentall2, M. Stegall3, M. Naesens4, I. Batal5, S. Coley6, J. Gill7, M. Mengel8, L. Cornell3, M. P. Alexander2, T. Coates9, C. Legendre10, P. Reese11, c. lefaucheur12, O. Aubert1, A. Loupy1

  • Development and Validation of a Medication Safety Dashboard in Veteran Transplant Recipients: Preliminary Results of a Multicenter Cluster-Randomized Controlled Clinical Trial

    D. Taber1, R. Felkner2, K. Rife3, D. Cooney3, S. Laforest3, E. Santa4, N. Super5, C. Hall6, T. Goddard1, R. Alexander1

  • Development and Validation of an Integrative DD-CFDNA System to Predict Allograft Rejection: A Population Based Study

    O. Aubert, R. Brousse, J. Gueguen, M. Racape, C. Lefaucheur, A. Loupy

  • Development of a Comprehensive Banff Automation System for Kidney Allograft Precision Diagnostics

    D. Yoo1, J. Gueguen1, G. Divard1, M. Raynaud1, V. Goutaudier1, M. Rabant1, M. Haas2, M. Mengel3, O. Aubert1, A. Loupy1

  • Development of a Culturally Sensitive Chatbot to Inform Living Donor Candidates of African Ancestry About Apol1 Genetic Testing

    E. J. Gordon1, P. Waite2, J. Gacki-Smith2, D. Duquette3, A. Agrawal1, J. Friedewald1, S. Savage4, E. Simmons5, M. Cooper6, A. Gilbert6, C. Wicklund7

  • Development of a Dynamic Map of Peripheral Myeloid Cells Associated with Acute Rejection of Vascularized Composite Tissue Allografts

    J. T. Harden1, S. E. Fuentes1, X. Wang1, J. Enriquez1, A. Reitsma1, C. 0. Esquivel2, O. M. Martinez3, S. M. Krams3

  • Development of a Patient-Reported Outcome Measure of Neurological Side Effects from Immunosuppression in Kidney Transplant Recipients

    C. Hurt1, G. J. Greene1, J. Friedewald2, D. P. Ladner2, A. Waterman3, D. Cella1, D. Peipert1

  • Development of a Portable Device to Quantify Hepatic Steatosis in Donated Livers Using an AI Algorithm

    S. Klinkachorn1, C. J. Tsoi-A-Sue2, R. R. Narayan2, M. L. Melcher2

  • Development of a Radiomics-Based Model to Predict Graft Fibrosis in Liver Transplant Recipients: A Pilot Study

    F. Qazi Arisar1, E. Salinas-Miranda2, H. Ale Ali2, K. Lajkosz3, C. Chen1, A. Azhie1, G. M. Healy2, D. Deniffel2, M. A. Haider2, M. Bhat1

  • Development of an M2 Macrophage Signature in Spontaneously Accepted Kidney Allografts

    M. T. Guinn1, E. S. Szuter1, T. Yokose1, J. Ge2, B. Kwon1, I. Rosales3, P. S. Russell1, A. G. Cuenca2, J. C. Madsen4, R. B. Colvin3, A. Alessandrini1

  • Development of Diagnostic Algorithms for Peri-Operative Error Cause and Effect Analysis in Renal Transplant Surgery

    P. Gogalniceanu1, H. Maple1, G. Papadakis1, P. Chandak1, I. Loukopoulos1, J. Olsburgh1, N. Kessaris1, F. Calder1, N. Sevdalis2, N. Mamode1

  • Development of Ex-Situ Hypothermic and Normothermic Reperfusion as an Innovative Method to Preserve an Assess Uterus: A Preliminary Result

    L. Dion1, E. Loiseau2, B. Mesnard3, G. Blancho4, T. Thubert5, J. Hervouet4, D. Minault4, S. Le Bas-Bernardet6, R. Josien6, V. Lavoué1, J. Branchereau7

  • Development Process of Minimally Invasive Living Donor Liver Transplantation (from Pure Laparoscopic Explant Hepatectomy to Robotic Graft Implantation)

    K. Suh, S. Hong, S. Lee, S. Suh, S. Hong, E. Han, Y. Choi, N. Yi, K. Lee

  • Diabetes is a Significant and Independent Predictor for Tacrolimus Immediate Release (IR) and LCP-Tacrolimus (LCP) Conversion Ratios

    K. S. Coffman, N. Patel, F. Bartlett, J. Newman, S. Patel, T. Sprague, N. Rao, E. Andrade, M. Casey, V. Rohan, D. DuBay, D. Taber

  • Diabetes Mellitus and Blood Glucose Variability Increases the 30-day Readmission Rate After Kidney Transplantation

    H. Chakkera1, C. Cook1, S. Saghafian2, A. Orfanoudaki3

  • Diagnosis of Acute Graft Rejection After Kidney Transplantation Using Metabolome Analysis by Liquid Biopsy Approach

    H. Iwamoto1, O. Konno1, Y. Kihara1, M. Okihara1, I. Akashi1, T. Ueno1, M. Sugimoto2

  • Diagnostic Performance of Donor-Derived Cell-Free DNA Assay (AlloSure®) in Kidney Transplant Recipients with Graft Dysfunction: A Single Center Study

    M. S. Naseer1, H. Shokouh-Amiri2, T. Creamer1, R. McMillan2, S. Tandukar1, D. Aultman1, G. B. Zibari1, N. Singh1

  • Dialysis Patient Perspectives on Obesity as a Barrier to Kidney Transplantation

    S. S. Hingorany, A. Klassen, B. Milliron, J. Sweeting, J. Lee, R. HaileSelasse, B. Gunen, M. N. Harhay

  • Dietary Sodium Intake And Blood Pressure In Living Kidney Donors (SPLID): Rationale And Design Of A Pilot Single-center Crossover Single-blind Randomized Controlled Trial

    E. Tantisattamo1, U. G. Reddy1, A. J. Ferrey1, H. Ichii2, D. C. Dafoe2, H. Moradi1, C. M. Rhee1, K. Kalantar-Zadeh1

  • Differences in Acceptance to the Kidney Transplant List

    J. Cotton1, K. Perry2, N. Costa3, S. Niederhaus1

  • Differences in Medication Adherence Between Preemptive and Post-Dialysis Young Kidney Transplant Recipients

    Y. Vaisbourd1, E. Samson2, A. De Simone2, M. Dahhou2, B. Foster3

  • Differences in Post-Liver Transplant Hospitalizations by Patient Race

    K. Ross-Driscoll1, R. Lynch1, J. Wedd2, R. Patzer1

  • Differences in Strength and Longevity of SARS-CoV-2-Specific Adaptive Immunity Between Convalescent and Vaccinated SOT Patients and Immunocompetent Individuals

    L. Donadeu1, S. Gomez1, A. Fava'2, E. Crespo1, F. Moreso3, M. Lopez3, L. Lladó4, J. González4, I. Campos3, M. Muñoz3, J. Quintero3, J. Esperalba3, O. Bestard3

  • Differences of Fk-Binding Protein 12 and P-Glycoprotein Explain the Differences in the Intracellular Tacrolimus Concentration of T Lymphocytes and Monocytes

    S. Udomkarnjananun, C. Baan, B. de Winter, D. Hesselink

  • Differential Impact of Subclinical Kidney Transplant Rejection in Young Adults

    S. Raza1, G. Agarwal1, H. Fatima1, R. Gaston1, V. Hauptfeld-Dolesjek1, B. Julian1, C. Kew1, V. Kumar1, S. Mehta1, S. Ong1, F. Rosenblum1, G. Towns1, R. Mannon2, M. Seifert1

  • Differentially Methylated Genes Predict Post-Transplant Relapse of Unresectable Hepatoblastoma

    M. Ningappa1, M. Muarya2, C. Ashokkumar1, H. Hakonarson3, S. Subramaniam4, R. Sindhi1

  • Differing Gene Expression Profiles and Signaling Pathways Observed Between Alloreactive and Tolerant T Cells in a Recipient Following Bilateral Orthotopic Lung Transplant (BOLT) and Bone Marrow Transplant (BMT) from the Same Cadaveric UNOS Donor

    P. Szabolcs, E. Garchar, D. Rajasundaram, X. Chen

  • Digital Spatial Profiling of Kidney Allograft Biopsies with Chronic Allograft Dysfunction in African American Transplant Recipients

    C. R. Dorr1, S. A. Elmer1, B. Wu2, B. Guo2, J. Czyzyk2, G. Crary3, G. Onyeaghala1, W. Oetting2, P. Jacobson2, R. B. Mannon4, G. Agarwal5, J. Maltzman6, A. Matas2, A. Israni3

  • Direct Central Ambulatory Venoarterial Extracorporeal Membrane Oxygenation and Double Lung Transplantation without Graft Reduction with Extreme Mediastinal Shift

    A. Gorton1, S. Keshavamurthy2

  • Direct Comparison of Clinical Outcomes with Belatacept-Based Regimens to Calcineurin Inhibitors Among DCD and/or High KDPI Kidney Transplant Recipients

    A. Rizvi1, M. Kueht2, S. Hussain3, J. Fair2, R. Ramirez4, A. Gamilla-Crudo5, M. Mujtaba5

  • Direct Health Care Costs Before and After Kidney Transplantation in Germany – A Longitudinal Analysis Based on Claims Data

    S. Ronicke1, K. Budde1, D. Schmidt2, W. Düttmann1, M. G. Naik1, C. J. Wagner3, J. Freitag3, B. Osmanodja1

  • Direct Oral Anticoagulants versus Warfarin in Adult Heart Transplant Recipients

    L. Shitanishi, A. Fan, T. Khuu, R. Ardehali

  • Direct Procurement of Heart and Lungs from a Controlled DCD Donor with Ongoing Abdominal Normothermic Regional Perfusion (aNRP) – A Synchronized Retrieval

    M. Husain1, A. Jothidasan1, C. Zeschky1, M. Osman2, M. Berman2, R. Gaurav3, A. Butler3, C. Watson3, B. Stutchfield4, I. Currie5, G. Oniscu5, J. Dunning1, U. Stock1

  • Discordant Histological Findings During Acute Rejection in a Combined Face and Hand Transplant Recipient

    O. C. Onuh1, J. Trilles1, W. J. Rifkin1, H. Brydges1, B. F. Chaya1, R. Rodriguez Colon1, D. Boczar1, D. J. Ceradini1, E. D. Rodriguez1, B. E. Gelb2

  • Discovery of Risk Factor Control Targets Using Machine Learning and Network Analysis for One-Year Renal Allograft Dysfunction

    Y. Lee1, M. Hong2, J. Kong3, O. Kwon4, C. Jung5, J. Yang6, M. Kim7, H. Han8, S. Nam9

  • Discrepancy Rates Between Histology (HIST) and Molecular Diagnosis (MDX) of T-cell Mediated Rejection (TCMR) Depend on Choice of Bioinformatics Pipeline

    M. Ellison, D. Spagnolo, P. Randhawa

  • Disparities Associated with Road Travel Distance of Living Kidney Donors in the United States: An SRTR Analysis

    K. Nijhar1, A. Kernodle1, J. D. Motter1, K. Khoo1, A. Massie2, E. King3, D. Segev1

  • Disparities in Liver Transplant Access for HCC Patients Based on Patient Blood Type and the Intensity of Competition for Organs Under MMAT-3

    A. J. Ahearn, H. Chowdhry, J. L. Dodge, K. Zhou

  • Disparities in Liver Transplantation in Patients with HCC Diagnosis

    C. Warren1, A. Zarrinpar2

  • Disparities in Low Respiratory Vaccination Among Solid Organ Transplant Recipients

    J. R. Felzer1, A. M. LeMahieu2, L. J. Finney Rutten2, Y. Juhn3, C. Wi3, R. M. Jacobson3, C. C. Kennedy1

  • Disparity In U.S. Organ Donation And Transplantation During A Global Pandemic

    J. Buggs1, K. Dhanireddy1, A. Kumar2, N. Kemmer3

  • Disruption of B Cell Population is Associated with Increased Infections in Pediatric Transplant Recipients

    B. Geng, L. Loop, C. Anterasian, D. Mortazavi, J. Kitsen, C. Collins, K. Newton, E. Ingulli

  • Distinct Phenotypes of Kidney Transplant Recipients Aged 80 Years or Older in the United States by Machine Learning Consensus Clustering

    S. A. Mao1, C. Thongprayoon2, M. A. Mao3, C. C. Jadlowiec4, N. Leeaphorn5, M. Cooper6, W. Cheungpasitporn2

  • Distinct Phenotypes of Kidney Transplant Recipients with Delayed Graft Function Identified Through Machine Learning Consensus Clustering

    C. Jadlowiec1, C. Thongprayoon2, N. Leeaphorn3, W. Kaewput4, P. Pattharanitima5, M. Cooper6, W. Cheungpasitporn2

  • Disulfide HMGB1 Reprograms Macrophages to Induce Alloimmunity via TLR4 and TLR9 Pathways Following Ischemia-Reperfusion Injury in Human Orthotopic Liver Transplantation

    A. Q. Terry1, R. A. Sosa1, F. Kaldas2, R. Busuttil3, D. Gjertson1, J. Kupiec-Weglinski1, E. Reed1

  • Do Clinical & Pathologic Signs of Rejection Develop Following Transplantation of Tissue Containing Non-Autologous Mitochondria in an Autologous Nuclear Cloned Host?

    S. Jacob1, M. L. Baack2, A. Savinov3, P. J. Wettstein4

  • Do CMS Oversight and the Systems Improvement Agreement Really Change Institutional Behavior?

    C. Hoopes

  • Do Early Trends of Donor-Derived Cell Free DNA Predict Long Term Kidney Allograft Outcomes?

    S. Park1, K. Guo2, L. Zhao2, C. Rebello2, J. Friedewald2

  • Do Social Support Requirements Delay Time to Listing Decision in Liver Candidates?

    M. Jesse1, A. Peleman1, M. Karrick1, F. Nimri1, N. Parikh2, A. Segal1, D. Moonka1, M. Abouljoud1, A. Yoshida1

  • Do Videos Work Better Than Digital Ads at Reaching Audiences? Examining Which Message Types Engage and Encourage Further Exploration of Living Donation

    L. A. Davis1, A. Livingston2, A. Waterman3

  • Does a Second Transplant Increase the Risk for CMV Infection? An Evaluation of the Incidence of CMV Viremia in the Previously Transplanted Kidney Recipient

    J. Byrns1, G. Katz-Greenberg2

  • Does ABO/HLA Matching Matter in Uterus Transplantation?

    L. Johannesson1, M. Askar1, A. Wall2, G. Testa1

  • Does Black Race Modify the Risk of Transplant Failure Associated with HLA Mismatch in First Adult Kidney Allografts from Deceased Donors?

    K. Atiemo

  • Does Comprehensive Geriatric Assessment Impact Risk Assessment for Potential Kidney Transplant Patients?

    J. Patel1, S. Hussain2, D. Mills1, A. Edobor3, E. Walters3, J. Williams3, Y. Kyeso2, J. F. Fung3, R. Barth3, D. Rubin4, M. Huisingh-Scheetz2, M. Martinchek5, M. L. Madariaga3

  • Does Dialysis Modality or Duration Influence Outcomes in Simultaneous Pancreas-Kidney Transplant Recipients?

    M. Garner1, B. Sharda2, A. Farney3, J. Rogers2, G. Orlando3, C. Jay4, A. Reeves-Daniel5, A. Mena-Gutierrez3, N. Sakhovskaya3, R. Stratta6

  • Does Donor-to-Recipient Weight Mismatch Influence Short Term Outcomes of Deceased Donor Kidney Transplantation?

    L. Sabbagh, M. Killackey, H. Jeon, K. Atiemo, A. Paramesh, A. Vijay

  • Does Gene Mutation Carrier Status Contribute to Risk of Kidney Failure?

    S. A. Muhsin, R. Saranu, B. Schreiber, E. Milford, M. Y. Yeung, A. Chandraker

  • Does Machine Perfusion of Heart for Donation After Cardiac Death (DCD) Transplantation Affect Other Organ Outcomes?

    R. Misawa1, K. Okumura2, H. Sogawa1, G. Veillette1, A. Dhand3, R. Bodin4, D. C. Wolf4, B. Partiula4, D. John1, T. Diflo5, S. Nishida1

  • Does the New Kidney Transplant Allocation System Impact Delayed Graft Function Rates After Kidney Transplantation?

    P. N. Chotai1, F. Siddiqui2, A. Logan3, K. Washburn4, A. Schenk5, A. Limkemann3

  • Domino Living Donor Kidney Transplant Following Therapeutic Nephrectomy for Renal Artery Stenosis with Arterial Reconstruction and Viability Assessment Using Ex Vivo Normothermic Perfusion: A Case Series

    R. Pearson1, J. Wubetu1, K. Stevenson1, E. Aitken1, A. Jackson1, M. Clancy2, D. B. Kingsmore1

  • Donor and Recipient Age Matching for Kidney Transplantation: A Machine Learning Approach

    J. Kim, J. Ahn, A. Massie, D. Segev, S. Bae

  • Donor App Increases Awareness and Overall Rates of Living Kidney Donation

    T. Shamaa1, I. Bajjoka1, H. Kandalaft1, R. Prashar2, M. Callaghan1, C. Crombez1, S. J. Serra1, M. Abouljoud1, J. Denny1

  • Donor Black Race Modifies the Association Between Increasing Donor Age and Graft Failure Following Living Kidney Transplantation

    K. Atiemo, R. Baudier, A. Anderson

  • Donor Derived Cell-Free DNA Median and Distribution in Pediatric Heart Transplant Patients

    J. N. Gray1, J. Miles1, K. Oreschak1, L. Jenkins1, B. Feingold2

  • Donor Derived Transmissions 2020: Analysis of the OPTN Ad Hoc Disease Transmission Advisory Committee (DTAC) with a Focus on COVID-19

    R. M. La Hoz1, A. Agarwal1, G. Berry1, K. Dunn1, J. Goldman1, S. Ho1, M. Kittleson1, D. H. Lee1, D. J. Levine1, C. Marboe1, G. Marklin1, S. Pouch1, R. Razonable1, S. Taimur1, H. Te1, A. Woolley1, C. Fox2, C. Jett2, S. Booker2, D. K. Klassen2, L. Danziger-Isakov1

  • Donor Disposition AI Model to Predict Transplant for Recovered Deceased Donor Kidneys

    L. Ashiku1, R. Threlkeld1, C. Dagli1, M. Schnitzler2, C. Canfield1, K. Lentine2, H. Randall2

  • Donor Exercise Preconditioning Protects Murine Orthotopic Liver Grafts During Ischemia Reperfusion Injury

    H. O. Yazdani, C. Kaltenmeier, R. Nakano, R. L. Simmons, D. A. Geller, S. Tohme

  • Donor Factors Do Not Discriminate Living Donor Kidney Transplant Outcomes and Should Not Be Used to Promote the Use of Compatible Pairs in Kidney Paired Donation Programs

    G. Irish1, D. Chang2, S. Chadban1, N. Boudville1, S. Campbell1, J. Kanellis1, L. McMichael2, E. Sharples3, M. Kadatz2, J. Gill2, P. Clayton1

  • Donor Genetic Background Predisposes Differentiation and Accumulation of Regulatory T Cells in the Kidney Allografts

    X. Lai1, J. Wang1, S. Han1, C. Chunlei1, L. VanOsdol1, L. Gallon2, J. Leventhal2, M. Kandpal1, Z. Zhang1

  • Donor Hospital Referrals of Potential Deceased Donors Slow Down on Weekends

    A. L. Friedman, E. Marquez, H. Ghali

  • Donor Kidney-Resident Passenger Macrophages Promote CCL8-CCR8 Mediated Early Allograft Inflammation

    A. Dangi1, I. Husain2, N. Natesh3, X. Shen3, J. Kwun4, X. Luo5

  • Donor Kidneys from Communities with Higher Deprivation Are Significantly More Likely to be Discarded

    J. Schold1, A. Huml1, E. Poggio1, E. Dewey1, R. Buchalter1, S. Husain2, S. Mohan2

  • Donor Macrophage Depletion Improves Kidney Graft Function Despite Long Cold Ischemia

    C. Jordan1, A. Dangi2, X. Luo1

  • Donor Organ Utilization And Transplantation Outcomes In Donation After Circulatory Death Using Thoracoabdominal Normothermic Regional Perfusion

    M. Urban, S. Merani, N. W. Markin, A. Castleberry, J. Um

  • Donor Terminal Creatinine – Does It Matter?

    V. G. Menon, Y. Wert, W. Hoffman, D. Ladie, M. Singh, M. Waybill, H. Yang

  • Donor-Derived Carbapenem-Resistant Gram-Negative Infections: Risk Mitigation Strategy in Solid Organ Transplant Improves Recipients Safety and Could Expand Donor Pool

    A. Mularoni1, E. Graziano1, M. Campanella1, A. Cervo2, M. Peghin3, F. Barbera1, P. Conaldi1, A. Luca1, P. A. Grossi4

  • Donor-Derived Cell-Free DNA (dd-cfDNA) for Assessment of Response After Treatment of Allograft Rejection

    R. Gohh1, J. Klein2, M. Jagadeesan3, V. Rao4, M. Weir5, H. Gilligan6, G. Shekhtman7, N. Agrawal8, Y. Fu9, E. Akalin10

  • Donor-Derived Cell-Free DNA Across the Spectrum of Solid Organ Transplantation

    S. R. Potter1, J. Miles2, K. Qu2, R. Woodward2, S. Dholakia2

  • Donor-Derived Cell-Free DNA and Gene Expression Profiling for Surveillance of Renal Allograft Injury and Rejection

    A. N. Carrier, A. Crane, M. Pinedo, A. Bartosic, A. Haririan, J. R. Scalea, M. R. Weir, J. S. Bromberg

  • Donor-Derived Cell-Free DNA as a Biomarker of T Cell Mediated Rejection in Pediatric Kidney Transplant Patients

    R. Dandamudi1, S. Federman2, R. Woodward2, S. Dholakia2, L. Walther1, V. Dharnidharka1

  • Donor-Derived Cell-Free DNA Testing in Kidney Transplantation: Do One-Month Values Have Any Prognostic Significance?

    B. K. Sharda1, M. Garner1, A. Farney1, G. Orlando2, J. Rogers2, C. Jay3, A. Daniel1, A. Guiterrez1, N. Sakhovskaya1, R. Stratta1

  • Donor-Derived Cell-Free DNA Trends Before and After Rejection Vary Based on Timing of Rejection

    C. Rebello1, K. Guo1, S. Park2, B. Kinsella1, L. Zhao1, J. Friedewald1

  • Donor-Derived Duodenal Adenocarcinoma of a Bladder-Drained Pancreas Allograft

    D. Isaacson1, J. Steggerda1, Y. Xue1, G. B. Auffenberg2, N. N. Katariya3

  • Donor-Derived IL-33 Plays a Critical Role in Lung Allograft Acceptance

    Y. Guo1, Z. Mei1, M. Khalil1, D. Li1, A. Banerjee1, A. Gelman2, D. Kreisel2, A. Krupnick1

  • Donor-Specific Hyporesponsiveness Following Kidney Transplantation is Explained by Progressive Loss of Donor-Reactive Polyfunctional Cd4+ Effector Memory T Cells

    A. C. van der List, N. H. Litjens, M. Klepper, F. Prevoo, M. G. Betjes

  • Donor-Specific T Cell Senescence In Operationally Tolerant Liver Transplant Recipients

    K. Deng1, N. Tanimine2, C. Breeden3, B. Burrell3, G. Gaile3, K. Lee1, R. Matheson1, F. Qiang1, C. Rickert1, C. LeGuern1, J. Markmann1

  • Donor-Specificb Cell Dysfunction and Suppressive Ability Are Differentially Induced in Cob-Mediated Transplantation Tolerance

    S. Durgam1, D. Yin1, M. Alegre2, A. Chong1

  • Donor/Recipient Variabilities and Dd-cfdna Level

    I. Gani1, L. Mulloy1, R. Mallavarapu1, M. Saeed1, R. Kapoor2, A. Mirza1

  • DonorNet Procurement Photos and Their Association with Kidney Utilization

    M. Stuart1, A. M. Placona1, C. Martinez1, K. Andreoni2

  • Donors’ Perceptions of Uterus Donation Motivations, Informed Consent and Value: A Qualitative Study of Dallas Uterus Transplant Study (duets) Participants

    A. Wall1, J. Hagen2, V. Reddy3, E. Gordon4, L. Johannesson1, G. Testa1

  • Dual Deceased Donor Kidney Transplants: Maximizing Utilization of Suboptimal Kidneys

    S. Nagaraju, S. Vaishnav, K. Boggs, T. Cook, A. Jones, J. B. Africa

  • Dual Therapy with Esculin and Erythropoietin Attenuates Renal Ischemia-Reperfusion Injury via P2x7 Receptor and Nlrp3 Inflammasome Inhibition, and Pi3k/akt Activation

    E. Hafiz1, W. H. El-Maadawy2, M. Hassan3, M. H. Badawy4, S. Eldahshan4, A. AbuSeada5

  • Duration of Brain Death Does Not Impact Short Term Outcomes in Kidney Transplantation

    A. M. Hawxby1, R. Ketcham2, J. P. Orlowski3, R. A. Squires2, C. Hostetler2

  • Dynamic Changes and Roles of Specialized Pro-resolving Lipid Meditators in the Initiation and Resolution Process of Lung Ischemia-Reperfusion Injury in Rats

    H. Oda1, S. Tanaka1, M. Shinohara2, Y. Morimura1, Y. Yokoyama1, H. Kayawake1, Y. Yamada1, A. Ohsumi1, D. Nakajima1, H. Date1

  • Dynamic Changes in Titer and Specificity Autoantibodies in Chronic Bm12 to B/6 Kidney Rejection

    I. Sayin1, D. Yin1, D. Ghosh2, M. Clark2, A. Chong1

  • Dynamic Changes of Serum Soluble B Cell Activating Factor in Kidney Transplant with De Novo Donor Specific Antibody

    S. Wu1, X. Su1, Y. Gao1, Y. Wei1, Q. Ye1, M. Huang2, Y. Chen1, J. Wang1, Q. Zhang3, Q. Fu1, J. Li2, H. Huang2, B. Xu2, H. Zhang1, L. Liu2, C. Wang2

  • Dynamic Risk Prediction of Kidney Graft Failure After Deceased Donor Transplant

    D. G. Hu1, H. Thiessen Philbrook1, S. Mohan2, I. Hall3, M. Doshi4, K. F. Kerr5, C. R. Parikh1

  • Dynapenia Among Kidney Transplant Candidates and Recipients in the United States

    A. S. Nalatwad1, X. Chen1, N. M. Chu1, S. P. Norman2, D. L. Segev1, M. McAdams-Demarco1

Jump to:  View All • a b c [d] e f g h i j k l m n o p q r s t u v w x y z

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences